NCT06284421 is a NA clinical trial of Shore durometer in Uterine Tone Disorders, sponsored by University of Chicago.

Who is sponsoring NCT06284421?

NCT06284421 is sponsored by University of Chicago.

What drugs are being tested in NCT06284421?

Interventions in NCT06284421: Shore durometer.

What condition does NCT06284421 study?

NCT06284421 studies Uterine Tone Disorders, Cesarean Section Complications.

Is NCT06284421 still recruiting?

NCT06284421 is currently recruiting now. Last updated 6 May 2025.

Last reviewed 2025-05-06 · How we verify

NCT06284421

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Durometer for Measuring Uterine Tone

Recruiting now NA Last updated 6 May 2025

What this trial tests

NA trial testing Shore durometer in Uterine Tone Disorders in 20 participants. Currently enrolling.

Timeline

8 February 2024

Primary endpoint
30 March 2026

30 August 2026

Quick facts

Lead sponsor	University of Chicago
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	20
Start date	8 February 2024
Primary completion	30 March 2026
Estimated completion	30 August 2026
Sites	1 location across United States

Drugs / interventions tested

Shore durometer

Conditions studied

Uterine Tone Disorders — all drugs for Uterine Tone Disorders →
Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

University of Chicago

Who can join

Adults 18 to 50, female only, with Uterine Tone Disorders or Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the use of a durometer to measure uterine tone in parturients undergoing cesarean delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Shore durometer

Trials testing the same drug.

NCT03898882 — Pharmacokinetics of Oxytocin at Cesarean Delivery · completed

Other University of Chicago trials

Trials by the same sponsor.

NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06284421 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Chicago
Last refreshed: 6 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06284421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing